Mrs. Ann Mclaughlin is a Chicago, Illinois based nurse practitioner. Active license number of Mrs. Ann Mclaughlin is 209-005348 in Illinois. His current practice location is 3860 W Ogden Ave, Chicago. Patients can reach him at 872-588-3000 or can fax him at 872-588-3021 and his NPI number (Unique professional ID assigned by NPPES) is 1063448413. Mrs. Ann Mclaughlin has completed additional training beyond basic nursing education and provides primary health care services in accordance with state nurse practice laws or statutes. NPs are trained to assess patient needs, order and interpret diagnostic and laboratory tests, diagnose disease, formulate and prescribe medications and treatment plans.
Complete Profile:
Mrs. Ann Mclaughlin speciality, credentials, practice address, contact phone number and fax are as below.
Patients can call on the below given phone number for appointment.
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1063448413
NPI Enumeration Date:
25 Jun, 2006
NPI Last Update On:
16 Mar, 2012
Medical Licenses:
NPs can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Mrs. Ann Mclaughlin are as mentioned below.
License Number
Specialization
State
Status
209-005348
Illinois
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
Mrs. Ann Mclaughlin 3860 W Ogden Ave, Chicago, Illinois
Zip:
60623-2460
Phone Number:
872-588-3000
Fax Number:
872-588-3021
Patients can reach Mrs. Ann Mclaughlin at 3860 W Ogden Ave, Chicago, Illinois or can call to book an appointment on 872-588-3000.
Comments/ Reviews:
Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 14 October, 2024.